TickerGuard
Buy Day today: Neutral (56) Mixed market breadth · no major macro event
FLGT

Fulgent Genetics Inc

Healthcare · Diagnostics & Research

22.20$ +3.0% vs. previous close Closing price · As of: Sep 25, 2026

Statements

Balance Sheet

Fulgent Genetics Inc (FLGT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 1,089 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet FLGT
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
1,358 1,235 1,230 1,232 1,234 1,220 1,206 1,200 1,215 1,214 1,156 1,089
550 508 387 399 327 354 417 429 507 550 479 455
84 97 55 65 58 55 67 88 118 50 23 26
468 424 306 312 213 258 320 293 376 336 276 257
55 57 59 64 65 77 80 85 79 92 76 71
4.9 5.8 6.5 7.0 8.6 8.4 8.6 9.0 10 11 12 12
142 22 22 22 22 22 22 22 25 25 54 54
144 143 141 139 137 135 133 131 135 133 154 149
97 102 103 103 99 91 83 88 94 107 112 93
61 73 76 76 74 73 66 71 72 85 90 72
2.9 5.1 3.3 2.7 1.9 1.9 1.8 1.7 2.0 1.9 2.4 2.3
16 15 20 20 20 18 18 19 18 19 21 16
– 3.0 2.5 2.5 2.5 2.5 2.0 2.0 2.0 2.0 1.5 1.5
1,259 1,136 1,130 1,133 1,138 1,133 1,127 1,117 1,126 1,112 1,050 1,002
761 633 620 611 596 590 579 560 553 530 505 476
30 30 30 30 30 31 31 31 31 31 31 28

Data as of: September 25, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?